𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A

✍ Scribed by Jan Fagerberg; Peter Ragnhammar; Maria Liljefors; Anna-Lena Hjelm; Håkan Mellstedt; Jan-Erik Frödin; J. Fagersberg


Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
137 KB
Volume
42
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Clinical outcome of colorectal cancer pa
✍ Gavin W. L. Denton; Lindy G. Durrant; Jack D. Hardcastle; Eric B. Austin; Herb F 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

## Abstract A human monoclonal anti‐idiotypic antibody (105AD7) has been developed which mimics a colorectal‐tumour‐associated antigen and induces cellular anti‐colorectal tumour immune responses in animals. Thirteen patients with advanced colorectal cancer were immunized with 105AD7 and their surv

Monoclonal anti-idiotypic antibody mimic
✍ Andreas Barth; Robert Waibel; Rolf A. Stahel 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 550 KB

We have previously described the tumor-asrocisited sialoglycoprotein antigen sGP,,,, defined by the murine LAME MAb. The antigen is characterized by strong memlbrane expression in a proportion of small-cell carcinomas of the lung, but little or no expression on normal tissues of epithelial or neural

Tumor-antigen-specific humoral immune re
✍ Hans-Peter Lehmann; Caroline Zwicky; Robert Waibel; Rolf A. Stahel 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 782 KB

## Abstract We have previously developed 3 monoclonal anti‐idiotypic antibodies (Ab2) of LOU rat origin directed against the binding site of the murine monoclonal IgM LAM8, which recognizes the small‐cell lung carcinoma (SCLC)‐associated sialoglycoprotein antigen sGP~90–135~. The aim of this study